Metabolic Characteristics of HER2-Low and HER2-Zero Breast Cancer
Author Information
Author(s): Gao Yuan, Yin Lei, Ma Linlin, Wu Caixia, Zhu Xiaojuan, Liu Hongjin, Liang Li, Chen Jinzhi, Chen Yulong, Ye Jingming, Xu Ling
Primary Institution: Peking University First Hospital
Hypothesis
This study aimed to comparatively analyze the metabolic characteristics and prognostic stratification of HER2-low and HER2-zero breast cancer using 18F-FDG PET/CT imaging.
Conclusion
The HR-positive HER2-low breast cancer exhibited a unique glucose metabolic profile, and HER2-zero patients with elevated metabolism had a poorer prognosis.
Supporting Evidence
- SUVmax and TLR were significantly higher in HER2-low than in HER2-zero in the HR-positive subgroup.
- The four metabolic parameters were significant predictors of disease-free survival in HER2-negative patients.
- Higher metabolism in HER2-zero patients was associated with a shorter disease-free survival.
Takeaway
This study looked at how different types of breast cancer, specifically HER2-low and HER2-zero, use sugar for energy, which can help doctors understand how to treat these cancers better.
Methodology
The study reviewed consecutive patients with newly diagnosed breast cancer who underwent 18F-FDG PET/CT prior to therapy, analyzing metabolic parameters and survival outcomes.
Potential Biases
Retrospective case collation may be prone to inadvertent bias.
Limitations
The sample size was insufficient for thorough analysis, and the retrospective nature may introduce bias.
Participant Demographics
The study included 256 women (99.2%) and 2 men (0.8%), with a mean age of 54 ± 12 years.
Statistical Information
P-Value
P < 0.01 for metabolic parameters predicting DFS.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website